[NFS-04] Neuroscience Frontier Symposium 04 Structure and propagation of aggregated proteins

[NFS-04-5] Deconstructing and Reconstructing Lewy Bodies: New insights into the role of alpha-synuclein in PD

^○Hilal A. Lashuel (École Polytechnique Fédérale de Lausanne (EPFL))

Dr. Hilal A. Lashuel received his B.Sc. degree in chemistry from Brooklyn College-City University of New York in 1994 and completed his doctoral studies at Texas A&M University and the Scripps Research Institute in 2000. In 2001, he moved to Harvard Medical School as a research fellow in the Center for Neurologic Diseases and was later promoted to an instructor in neurology at Harvard Medical School. In 2005 Dr. Lashuel joined the Brain Mind Institute at the Swiss Federal Institute of Technology Lausanne (École polytechnique fédérale de Lausanne, EPFL) as a tenure-track assistant professor in neurosciences. Currently, Dr. Lashuel is an associate professor of life sciences and the director of the laboratory of molecular and chemical biology of neurodegeneration. He is also the founder and CSO of ND BioSciences SA, a biotechnology company that is developing innovative technologies and solutions to accelerate the development of early diagnostics and therapies for neurodegenerative diseases. Dr. Lashuel was also a visiting Associate Professor at the Department of Neurology and Neurological Sciences at Stanford University (2012-2013) and served as the Executive Director of Qatar Biomedical Research Institute (QBRI), Qatar Foundation